Artificial Intelligence-Enabled Stool Analysis for Lactulose Titration Assistance in Hepatic Encephalopathy Through a Smartphone Application.

Journal: The American journal of gastroenterology
PMID: 38240303

Abstract

INTRODUCTION: Management of hepatic encephalopathy relies on self-titration of lactulose. In this feasibility trial, we assess an artificial intelligence-enabled tool to guide lactulose use through a smartphone application.

Authors

  • Beatriz Sordi Chara
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kamalpreet S Hara
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Daniel Penrice
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kathryn A Schmidt
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Blake A Kassmeyer
    Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, 200 1st Street SW, Rochester, MN 55902, USA.
  • Jacob Anstey
    Dieta Incorporated, Oak Park, California, USA.
  • David Tiede
    Dieta Incorporated, Oak Park, California, USA.
  • Patrick S Kamath
    Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MA, USA.
  • Vijay H Shah
    Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MA, USA.
  • Jasmohan S Bajaj
    Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia, USA.
  • Asaf Kraus
    Dieta Incorporated, Oak Park, California, USA.
  • Douglas A Simonetto
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Keywords

External Resources

Popular Topics
Recent Journals